Skip to main content
logo
NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.0920
-0.0080 (-8.00%)
May 29, 2026, 3:58 PM AEST

ASX:NSB Revenue

NeuroScientific Biopharmaceuticals had revenue of 317.91K AUD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 317.91K, down -85.63% year-over-year.

Revenue (ttm)
317.91K
Revenue Growth
-85.63%
P/S Ratio
96.25
Revenue / Employee
n/a
Employees
n/a
Market Cap
30.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025---
Jun 30, 20242.21M-2.74M-55.34%
Jun 30, 20234.95M--
Jun 30, 2022---
Jun 30, 2021958.77K--
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
EZZ Life Science Holdings61.40M
Neurotech International7.07M
Neurizon Therapeutics5.98M
Imugene3.94M
Noxopharm3.40M
Proteomics International Laboratories3.21M
Entropy Neurodynamics1.58M
Avecho Biotechnology1.24M
Revenue Rankings

NeuroScientific Biopharmaceuticals News

More News